Numinus Wellness Inc. (NUMIF)

0.0518 -0.0004 (-0.77%) At close: 02:53PM EDT

Numinus Wellness Inc.

666 Burrard Street
Suite 2500 Park Place
Vancouver, BC V6C 2X8
Canada
833 686 4687
https://www.numinus.com

Sector(s): Healthcare
Industry: Medical Care Facilities
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Payton Nyquvest	Founder, CEO & Chairman	202.73k	N/A	N/A
Mr. Michael Tan M.B.A.	President, COO & Director	160.05k	N/A	N/A
Dr. Paul Thielking M.D.	Chief Science & Medical Officer	416.82k	N/A	N/A
Dr. Reid J. Robison M.D., MBA	Chief Clinical Officer	476.36k	N/A	1977
Ms. Melony Valleau CPA	Interim Chief Financial Officer	N/A	N/A	1969
Jamie Kokoska	Vice President of Investor Relations	N/A	N/A	N/A
Ms. Paula Amy Hewitt	Senior VP, General Counsel & Chief Privacy Officer	N/A	N/A	1973
Mr. Ian Noble	Chief Communications Officer	N/A	N/A	N/A
Ms. Danielle Hinan	Vice President Marketing	N/A	N/A	N/A
Ms. Lea Bottoni	Vice President of People & Culture	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.

Corporate Governance

Numinus Wellness Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.